Related references
Note: Only part of the references are listed.The effect of imatinib (Glivec (R)) on scleroderma and normal dermal fibroblasts: A preclinical study
A. Soria et al.
DERMATOLOGY (2008)
Modulation of T-effector function by imatinib at the level of cytokine secretion
Christoph Leder et al.
EXPERIMENTAL HEMATOLOGY (2007)
Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia
Sergio A. Giralt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis
N. I. Chaudhary et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Allogeneic stem-cell transplantation with fludarabine and 2-Gy TBI-based conditioning regimen for chronic hematological malignancy:: A study of 25 consecutive patients and a literature review
J. B. Micol et al.
LEUKEMIA & LYMPHOMA (2007)
Recombinant human anti-transforming growth factor beta 1 antibody therapy in systemic sclerosis - A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192
Christopher P. Denton et al.
ARTHRITIS AND RHEUMATISM (2007)
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis
Joerg H. W. Distler et al.
ARTHRITIS AND RHEUMATISM (2007)
Imatinib mesylate inhibits fibrogenesis in asbestos-induced interstitial pneumonia
Kirsi Vuorinen et al.
EXPERIMENTAL LUNG RESEARCH (2007)
Imatinib mesylate inhibits platelet derived growth factor stimulated proliferation of rheumatoid synovial fibroblasts
Charlotta Sandler et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Imatinib: the narrow line between immune tolerance and activation
M Mohty et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Topical application of a peptide inhibitor of transforming growth factor-β1 ameliorates bleomycin-induced skin fibrosis
B Santiago et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia
JE Sanders et al.
BLOOD (2005)
Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT:: a GOELAMS trial
M Hunault et al.
BLOOD (2004)
Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CRI): an intention-to-treat analysis of the EORTC/GIMEMA AML-10 trial
S Suciu et al.
BLOOD (2003)
Imatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia
SG O'Brien et al.
SEMINARS IN HEMATOLOGY (2003)
Graft-versus-host disease - Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients
M Baudard et al.
BONE MARROW TRANSPLANTATION (2002)
Share Paper
